| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.035 | 0.4 |